Traditional Chinese drug composition for treating anaphylactoid purpura

Abstract

The present invention relates to a traditional Chinese drug composition for treating anaphylactoid purpura. The traditional Chinese drug composition comprises the following traditional Chinese drug raw materials, wherein the traditional Chinese drug raw materials comprise, by weight, 5-20 parts of mongolian milkvetch root, 5-15 parts of cassiabarktree twig, 5-20 parts of white peony root, 2-10 parts of prepared liauorice root, 5-20 parts of redroot gromwell, 5-20 parts of imperatae rhizome, 5-20 parts of hairyvein agrimonia herb, 2-10 parts of black cicada slough, 5-15 parts of common ducksmeat herb, 2-10 parts of common jujube, and 5-15 parts of pagodatree flower bud. The traditional Chinese drug composition of the present invention has effects of heat clearing and detoxicating, blood cooling and blood stasis dissipating, liver fire clearing and pathogenic fire reducing, yang enhancing and qi activating, qi benefiting, and artery and vein recovering, and provides a significant therapeutic effect for the anaphylactoid purpura. The treatment effect is reliable. The traditional Chinese drug composition has characteristics of wide sources of the drug components, simple preparation, mild medicine property, and no toxic and side-effect.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating allergic purpura. Background technique [0002] Allergic purpura, also known as purpura, is an allergic vasculitis that invades capillaries and arterioles of the skin or other organs. It mostly occurs in male children and is characterized by non-thrombocytopenic purpura, often accompanied by abdominal pain and joint symptoms. Manifested as skin petechiae, mostly around the joints of the lower extremities and buttocks, purpura is symmetrically distributed, appears in batches, varies in size and color, and can be fused into flakes, which generally subside within a few days, but can recur; Clinically, Western medicine for the treatment of allergic purpura mainly includes anti-allergic drugs, such as astemizole, chlorpheniramine, calcium gluconate; drugs that reduce vascular permeability...

AI Technical Summary

Problems solved by technology

However, due to physical reasons, patients with allergic purpura are susceptible to environmental changes, such as cold weather, fatigue, anger, colds, drinking, eating food that cause allergies, etc. These situations often lead to aggravation of the condition, and repeated occur

Therefore, Western medicine treatment of allergic purpura has the deficiency of treating the symptoms but not the root cause.